NO donor ameliorates ischemia-reperfusion injury of the rat liver with iNOS attenuation

Journal of Investigative Surgery

Volumn 18, Issue 4, 2005, Pages 193-200

  Kurabayashi, Makoto ^a   Takeyoshi, Izumi ^a   Yoshinari, Daisuke ^a   Koibuchi, Yukio ^a   Ohki, Takashi ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

Ischemia reperfusion; Liver; Nitric oxide

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DRUG VEHICLE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOFLURANE; LACTATE DEHYDROGENASE; NITRIC OXIDE DONOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATTENUATION; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG STRUCTURE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; L-LACTATE DEHYDROGENASE; LIVER; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRO COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 23944512824     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930500180156     Document Type: Article

References (43)

1. Liu P, Xu B, Hock CE, Nagele R, Sun FF, Wong PY. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol. 1998;275:H2191-H2198.
2. Pannen BH, Al-Adili F, Bauer M, Clemens MG, Geiger KK. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology. 1998;27:755-764.
3. Matsumura Y, Nishiura M, Deguchi S, Hashimoto N, Ogawa T, Seo R. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J Pharmacol Exp Ther. 1998;287:1084-1091.
4. Kalia N, Brown NJ, Hopkinson K, Stephenson TJ, Wood RF, Pockley AG. FK409 inhibits both local and remote organ damage after intestinal ischaemia. J Pathol. 2002;197:595-602.
5. Mohara J, Oshima K, Tsutsumi H, Takeyoshi I, Matsumoto K, Morishita Y. FK409 ameliorates ischemia-reperfusion injury in heart transplantation following 12-hour cold preservation. J Heart Lung Transplant. 2000;19:694-700.
6. Takeyoshi I, Otani Y, Yoshinari D, Kawashima Y, Ohwada S, Matsumoto K, Morishita Y. Beneficial effects of novel nitric oxide donor (FK409) on pulmonary ischemia-reperfusion injury in rats. J Heart Lung Transplant. 2000;19:185-192.
7. Aiba M, Takeyoshi I, Ohwada S, Kawashima Y, Iwanami K, Sunose Y, Yamada T, Tsutsumi H, Matsumoto K, Morishita Y. Novel nitric oxide donor (FK409) ameliorates liver damage during extended liver resection with warm ischemia in dogs. J Am Coll Surg. 2001;193:264-271.
8. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
9. Pronai L, Ichimori K, Nozaki H, Nakazawa H, Okino H, Carmichael AJ, Arroyo CM. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies. Eur J Biochem. 1991;202:923-930.
10. Kita Y, Hirasawa Y, Maeda K, Nishio M, Yoshida K. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur J Pharmacol. 1994;257:123-130.
11. Zhang JX, Pegoli W Jr, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol. 1994;266:G624-G632.
12. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88:4651-4655.
13. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radical Res Commun. 1993;18:195-199.
14. Martinez-Mier G, Toledo-Pereyra LH, McDuffie JE, Warner RL, Hsiao C, Stapleton SR, Ward PA. Exogenous nitric oxide downregulates MIP-2 and MIP-1alpha chemokines and MAPK p44/42 after ischemia and reperfusion of the rat kidney. J Invest Surg. 2002;15:287-296.
15. Liu P, Xu B, Spokas E, Lai PS, Wong PY. Role of endogenous nitric oxide in TNF-alpha and IL-1beta generation in hepatic ischemia-reperfusion. Shock. 2000;13:217-223.
16. Katori M, Tamaki T, Takahashi T, Tanaka M, Kawamura A, Kakita A. Prior induction of heat shock proteins by a nitric oxide donor attenuates cardiac ischemia/reperfusion injury in the rat. Transplantation. 2000;69:2530-2537.
17. Chatterjee PK, Patel NS, Sivarajah A, Kvale EO, Dugo L, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, Yaqoob MM, Thiemermann C. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int. 2003;63:853-865.
18. Ohmori H, Dhar DK, Nakashima Y, Hashimoto M, Masumura S, Nagasue N. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver. Transplantation. 1998;66:579-585.
19. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.
20. Sunose Y, Takeyoshi I, Ohwada S, Iwazaki S, Aiba M, Tomizawa N, Tsutsumi H, Oriuchi N, Matsumoto K, Morishita Y. The effect of FK409 -a nitric oxide donor- on canine lung transplantation. J Heart Lung Transplant. 2000;19:298-309.
21. Tanahashi Y, Takeyoshi I, Aiba M, Ohwada S, Matsumoto K, Morishita Y. The effects of FK409 on pulmonary ischemia-reperfusion injury in dogs. Transpl Int. 1999;12:402-407.
22. Kawata K, Takeyoshi I, Iwanami K, Sunose Y, Aiba M, Ohwada S, Matsumoto K, Morishita Y. A spontaneous nitric oxide donor ameliorates small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci. 2001;46:1748-1756.
23. Kita Y, Ohkubo K, Hirasawa Y, Katayama Y, Ohno M, Nishino S, Kato M, Yoshida K. FR144420, a novel, slow, nitric oxide-releasing agent. Eur J Pharmacol. 1995;275:125-130.
24. Kuntscher MV, Juran S, Menke H, Gebhard MM, Erdmann D, Germann G. The role of pre-ischaemic application of the nitric oxide donor spermine/nitric oxide complex in enhancing flap survival in a rat model. Br J Plast Surg. 2002;55:430-433.
25. Zhang JM, Orihashi K, Sueda T, Matsuura Y. Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours. Ann Thorac Surg. 2000;70:1601-1606.
26. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol. 1991;260:G355-G362.
27. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation. 1993;88:2451-2454.
28. Shimamura T, Zhu Y, Zhang S, Jin MB, Ishizaki N, Urakami A, Totsuka E, Kishida A, Lee R, Subbotin V, Furukawa H, Starzl TE, Todo S. Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg. 1999;188:43-52.
29. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Jr., Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
30. Biffl WL, Moore EE, Moore FA, Barnett C. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1. J Surg Res. 1996;63:328-332.
31. Yuan CH, Liu YF, Cheng Y, Zhao N, Li GC, Liang J, He SG. Protective effects of I-arginine on reperfusion injury after pancreaticoduodenal transplantation in rats. Hepatobiliary Pancreat Dis Int. 2004;3:349-354.
32. Hotter G, Closa D, Pi F, Prats N, Fernandez-Cruz L, Bulbena O, Gelpi E, Rosello-Catafau J. Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. Transplantation. 1995;59:417-421.
33. Cottart CH, Do L, Blanc MC, Vaubourdolle M, Descamps G, Durand D, Galen FX, Clot JP. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology. 1999;29:809-813.
34. Rivera-Chavez FA, Toledo-Pereyra LH, Dean RE, Crouch L, Ward PA. Exogenous and endogenous nitric oxide but not iNOS inhibition improves function and survival of ischemically injured livers. J Invest Surg. 2001;14:267-273.
35. Hammon JW Jr, Vinten-Johansen J. Augmentation of microvascular nitric oxide improves myocardial performance following global ischemia. J Card Surg. 1995;10:423-427.
36. Isobe M, Katsuramaki T, Hirata K, Kimura H, Nagayama M, Matsuno T. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation. 1999;68:803-813.
37. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, Billiar TR. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA. 1993;90:522-526.
38. Iadecola C, Zhang F, Casey R, Clark HB, Ross ME. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 1996;27:1373-1380.
39. Garcia-Criado FJ, Eleno N, Santos-Benito F, Valdunciel JJ, Reverte M, Lozano-Sanchez FS, Ludena MD, Gomez-Alonso A, Lopez-Novoa JM. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation. 1998;66:982-990.
40. Geller DA, Billiar TR. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 1998;17:7-23.
41. Buttery LD, Evans TJ, Springall DR, Carpenter A, Cohen J, Polak JM. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest. 1994;71:755-764.
42. Pollock JS, Forstermann U, Tracey WR, Nakane M. Nitric oxide synthase isozymes antibodies. Histochem J. 1995;27:738-744.
43. Vos TA, Gouw AS, Klok PA, Havinga R, van Goor H, Huitema S, Roelofsen H, Kuipers F, Jansen PL, Moshage H. Differential effects of nitric oxide synthase inhibitors on endotoxin-incluced liver damage in rats. Gastroenterology. 1997;113:1323-1333.